The story of Arkangel AI is not just about a groundbreaking startup; it’s about passion, perseverance, and the relentless pursuit of saving lives. At its core are Laura Velásquez and José David Gómez, two individuals driven by personal loss to create a solution that could prevent countless deaths due to late diagnoses of diseases. Let’s delve into their journey, the innovative technology they’ve developed, and the profound impact they aim to achieve.
A Personal Tragedy Ignites a Mission
For Laura Velásquez, the passing of her friend and business partner José David Gómez’s grandfather was a profound turning point. The realization that early detection could have altered the outcome of his battle with cancer sparked a fire within them. Motivated by grief and a shared determination to make a difference, they embarked on a mission to develop a solution that could identify diseases swiftly and accurately.
From Diverse Backgrounds to a Unified Vision
Velásquez and Gómez’s backgrounds may not have been rooted in medicine or computer science, but their diverse expertise proved invaluable. With Velásquez’s background in Marketing and Logistics and Gómez’s in Architecture, they brought a unique perspective to the table. In 2020, they founded Arkangel AI, a startup focused on leveraging artificial intelligence to detect diseases such as malaria, various cancers, and pulmonary fibrosis at an early stage.
The Birth of Arkangel AI
Arkangel AI emerged as a beacon of hope in the realm of healthcare innovation. Their software utilizes predictive modeling to analyze clinical data, offering insights that could potentially save millions of lives. From preventing the progression of chronic kidney disease to identifying indicators of mental health disorders, the scope of their technology is vast and transformative.
Recognition and Validation
The impact of Arkangel AI’s vision resonated globally, earning them prestigious accolades such as the Everis Global Award. Velásquez’s groundbreaking achievement as the first Latina woman to receive this honor underscored the significance of their work. Their innovative approach not only garnered attention but also garnered support from key stakeholders in the healthcare industry.
Managing Growth and Impact
Arkangel AI’s rapid growth can be attributed not only to the significance of its applications in public health but also to Velásquez’s exceptional management skills. Her background in project management and her entrepreneurial spirit propelled the startup forward. By 2022, Arkangel AI had secured partnerships with major pharmaceutical companies and healthcare providers, positioning itself as a leader in the field of AI-driven healthcare solutions.
Building on Experience and Expertise
Velásquez’s journey with Arkangel AI was not an isolated endeavor but rather the culmination of years of experience in the realm of innovation. Her tenure at Rappi and participation in entrepreneurial programs equipped her with the skills and insights needed to navigate the complexities of startup ventures. Prior entrepreneurial ventures further honed her ability to identify opportunities and execute ambitious ideas.
A Vision for the Future
Despite their remarkable achievements, Velásquez and Gómez remain steadfast in their mission to democratize healthcare access. Their vision extends beyond corporate success to making a tangible difference in the lives of billions. With aspirations to reach rural communities with limited access to healthcare, they aim to impact one billion patients worldwide by 2030.
Conclusion
The story of Arkangel AI is a testament to the power of innovation and human resilience in the face of adversity. Through Laura Velásquez and José David Gómez’s unwavering commitment, a simple idea blossomed into a revolutionary solution with the potential to redefine healthcare as we know it. As they continue to push the boundaries of what’s possible, their journey serves as inspiration for aspiring entrepreneurs and advocates for global health equity.
